Acrotech Biopharma

is a pharmaceutical company which is being built, as a global platform, to develop and commercialize innovative proprietary medications, starting with the US market.

The company

aims to launch scientifically advanced products to address unmet needs and deliver value to patients first as well as all healthcare stakeholders.

Acrotech Biopharma

aspires to be a patient-focused, research-based organization that strives to launch treatments which are accessible to the patients that need them.

Company Strategy

The company plans to grow through collaborations to build small molecule and biologics expertise to create breakthrough science that meaningfully changes the way we treat diseases.

Acrotech will continue building out its commercial infrastructure to maximize the value of its current and future products.

We aspire to achieve this by working with all key healthcare stakeholders starting from early on in clinical development all the way through commercialization.